Moreover, RASSF6 directly activates the Hippo pathway by enhancing the phosphorylation of STK4/3 and LATS1/2 kinases [39], thereby reinforcing its role as a critical upstream activator of Hippo tumor-suppressive signaling. The gene discussed is LATS1; the disease is neoplasm.